You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bcl-W

Showing 1 - 25 of 850
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DLBCL, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Tampa, Florida
  • +1 more
Jan 12, 2022

High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)

Recruiting
  • High Grade Serous Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
  • +2 more
Nov 28, 2022

Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Birmingham, Alabama
    A. Brent Carter
Aug 3, 2023

Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, Follicular Lymphoma Grade 3A Trial in Italy (OFATUMUMAB)

Completed
  • Follicular Lymphoma, Grade 1
  • +2 more
  • Alessandria, AL, Italy
  • +26 more
Jun 16, 2022

T-Cell Lymphoma Relapsed, T-Cell Lymphoma Refractory Trial in Italy (Venetoclax)

Active, not recruiting
  • T-Cell Lymphoma Relapsed
  • T-Cell Lymphoma Refractory
  • Aviano, Italy
  • +12 more
Dec 20, 2022

Dry Eye Trial in Birmingham (Amniotic membrane Omnigen[TM], Bandage soft Contact Lens OmniLenz[R])

Recruiting
  • Dry Eye
  • Amniotic membrane Omnigen[TM]
  • Bandage soft Contact Lens OmniLenz[R]
  • Birmingham, West Midlands, United Kingdom
    Aston University
Jul 25, 2022

Mantle Cell Lymphoma Refractory Trial (Ibrutinib, Venetoclax, Navitoclax)

Not yet recruiting
  • Mantle Cell Lymphoma Refractory
  • (no location specified)
May 16, 2023

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Boston

Active, not recruiting
  • Metastatic Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +6 more
  • Boston, Massachusetts
  • +1 more
Nov 8, 2022

Small Cell Lung Cancer Trial in Australia, United States (APG-1252, Paclitaxel)

Terminated
  • Small Cell Lung Cancer
  • Plantation, Florida
  • +7 more
Jul 8, 2022

Relapsed DLBCL, Refractory DLBCL Trial in Hackensack (ABT-199, Ibrutinib, Rituximab)

Active, not recruiting
  • Relapsed Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Oct 7, 2022

Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)

Recruiting
  • Advanced Breast Cancer
  • TQB3909 tablets
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Mar 16, 2023

Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia
  • Venclexta 100 MG Oral Tablet
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023

Neuroendocrine Tumors Trial in Guangzhou, Shanghai (Pelcitoclax)

Recruiting
  • Neuroendocrine Tumors
  • Guangzhou, Guangdong, China
  • +2 more
Jan 21, 2022

Hodgkin Lymphoma Trial in Guadalajara (Pentoxifylline, Placebo)

Recruiting
  • Hodgkin Lymphoma
  • Guadalajara, Jalisco, Mexico
    Hospital Civil de Guadalajara Fray Antonio Alcalde
Aug 4, 2022

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6

Withdrawn
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +9 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Transfusion-dependent Beta-Thalassemia Trial in Peshawar (Thalidomide)

Completed
  • Transfusion-dependent Beta-Thalassemia
  • Peshawar, Khyber Pakhtunkhwa, Pakistan
    Blood Care Clinic
Nov 19, 2023

Esophageal Squamous Cell Carcinoma Trial in Nanjing (Carrelizumab, Paclitaxel injection, Cisplatin)

Enrolling by invitation
  • Esophageal Squamous Cell Carcinoma
  • Nanjing, China
    The First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023

Obese Trial in Timisoara (Glucose 8 g coated beads (47% w/w), Glucose 12 g coated beads (47% w/w), Glucose 16 g coated beads

Completed
  • Obese
  • Glucose 8 g coated beads (47% w/w)
  • +4 more
  • Timisoara, Romania
    NovaClin Medical Research Center S.R.L
Feb 17, 2023

Dentin Sensitivity Trial in Shanghai (Sensodyne Sensitivity & Gum, Crest Cavity Protection Fresh Lime, Sensodyne Repair and

Not yet recruiting
  • Dentin Sensitivity
  • Sensodyne Sensitivity & Gum
  • +2 more
  • Shanghai, China
    Department of Preventive Dentistry, Shanghai Ninth People's Hosp
Feb 20, 2023

Atopic Dermatitis Trial in New York, Philadelphia (1.1% w/w AMTX-100 CF, 0.33% w/w AMTX-100 CF, 0.11% w/w AMTX-100 CF)

Active, not recruiting
  • Atopic Dermatitis
  • 1.1% w/w AMTX-100 CF
  • +3 more
  • New York, New York
  • +1 more
Sep 27, 2022

Gingivitis Trial in Fort Wayne (Stannous fluoride toothpaste, Sodium fluoride toothpaste)

Not yet recruiting
  • Gingivitis
  • Stannous fluoride toothpaste
  • Sodium fluoride toothpaste
  • Fort Wayne, Indiana
    Salus Research
Nov 16, 2023

Advanced Malignant Tumor Trial in Nanjing, Tianjin (TQB3909 Tablets)

Recruiting
  • Advanced Malignant Tumor
  • TQB3909 Tablets
  • Nanjing, Jiangsu, China
  • +1 more
Mar 3, 2022

Small Cell Lung Cancer and Other Solid Tumors Trial in Guangzhou (APG-1252)

Terminated
  • Small Cell Lung Cancer and Other Solid Tumors
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Aug 24, 2021

Visual Processing Speed and Objective Analysis of Ocular

Enrolling by invitation
  • Multiple Sclerosis
  • +3 more
  • Eye tracking
  • +3 more
  • Valladolid, Spain
    IOBA - Universidad de Valladolid
Jan 20, 2023

Healthy Trial in New Haven (PF-07295324, PF-07259955)

Active, not recruiting
  • Healthy
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Aug 3, 2022